Advances and challenges in the clinical practice of respiratory tract pharmacology and pharmacotherapy
DOI:
https://doi.org/10.56238/rcsv14n2-026Palavras-chave:
Pharmacotherapy, Asthma, Respiratory pharmacology, Bronchodilators, Smoking cessationResumo
This paper addresses the advances and challenges in the clinical practice of respiratory tract pharmacology and pharmacotherapy. Respiratory pharmacology has evolved significantly, offering a wide range of medications for the treatment of conditions such as asthma and chronic obstructive pulmonary disease (COPD). Bronchodilators, inhaled corticosteroids, and risk factor modification strategies, such as smoking cessation, are key to improving lung function and reducing exacerbations.
The use of modern drugs, as highlighted in "Goodman & Gilman's: The Pharmacological Basis of Therapeutics", is complemented by updated guidelines, such as those of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the Brazilian Society of Pulmonology and Phthisiology. These guidelines aim not only to relieve symptoms but also to promote an integrated approach that improves patients' quality of life.
Effective implementation of these strategies requires not only up-to-date scientific knowledge, but also public health policies that promote the rational use of medicines and educational interventions. Therefore, this study underscores the importance of a multidisciplinary approach to address the complex challenges associated with chronic respiratory diseases.
Referências
ANVISA - Agência Nacional de Vigilância Sanitária. Guia para condução de estudos de equivalência farmacêutica de medicamentos sob a forma farmacêutica cápsula de gelatina dura. Brasília, DF: ANVISA, 2017.
BRUNTON, L. L.; HILAL-DANDAN, R.; KNOLLMANN, B. C. (Eds.). Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 13. ed. New York, NY: McGraw-Hill Education, 2018.
CASTRO-RODRIGUEZ, J. A.; RODRIGO, G. J. β-agonists through the ages: Where are we now? Respiratory Medicine, v. 104, n. 5, p. 673-679, 2010. Disponível em: <https://doi.org/10.1016/j.rmed.2009.12.008>.
GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report. Disponível em: <https://goldcopd.org/gold-reports/>.
MARTINS, M. A.; MARTINS, C. S. Farmacologia Clínica para Fisioterapeutas. 2. ed. São Paulo: Manole, 2019.
RANG, H. P.; DALE, M. M.; RITTER, J. M.; FLOWER, R. J.; HENDERSON, G. (Eds.). Rang & Dale's Pharmacology. 9. ed. London, UK: Elsevier, 2019.
SOCIEDADE BRASILEIRA DE PNEUMOLOGIA E TISIOLOGIA. Diretrizes para cessação do tabagismo. Jornal Brasileiro de Pneumologia, v. 45, n. 1, p. 1-15, 2019. Disponível em: <https://doi.org/10.1590/S1806-37132009000500012>.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2024 Revista Científica Sistemática
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.